# TIMBER PHARMACEUTICALS INC (TMBRQ)

> Institutional ownership reported to the SEC as of Q3 2023, from Form 13F filings. Source: https://holderbook.com/stocks/TMBRQ/

- Reporting holders: 11
- Reported value: $1.6M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Tudor Investment Corp Et Al](https://holderbook.com/funds/923093-tudor-investment-corp-et-al/) | $746.8K | 251,037 | 0.0% | 1 |
| [PenderFund Capital Management Ltd.](https://holderbook.com/funds/1706164-penderfund-capital-management-ltd/) | $391.0K | 96,790 | 0.1% | 1 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $134.2K | 45,105 | 0.0% | 1 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $115.1K | 38,687 | 0.0% | 4 |
| [Yakira Capital Management, Inc.](https://holderbook.com/funds/1584639-yakira-capital-management-inc/) | $78.4K | 26,366 | 0.0% | 1 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $66.3K | 22,292 | 0.0% | 4 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $48.4K | 16,260 | 0.0% | 3 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $43.0K | 14,442 | 0.0% | 3 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $5.3K | 1,797 | 0.0% | 3 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $4.9K | 1,659 | 0.0% | 4 |
| [WELLS FARGO & COMPANY/MN](https://holderbook.com/funds/72971-wells-fargo-company-mn/) | $65 | 22 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2023 | 11 | $1.6M |
| Q2 2023 | 9 | $267.3K |
| Q1 2023 | 13 | $402.5K |
| Q4 2022 | 11 | $107.1K |